BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7499329)

  • 1. Growth inhibition of hepatoma cells induced by vitamin K and its analogs.
    Nishikawa Y; Carr BI; Wang M; Kar S; Finn F; Dowd P; Zheng ZB; Kerns J; Naganathan S
    J Biol Chem; 1995 Nov; 270(47):28304-10. PubMed ID: 7499329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K vitamins, PTP antagonism, and cell growth arrest.
    Carr BI; Wang Z; Kar S
    J Cell Physiol; 2002 Dec; 193(3):263-74. PubMed ID: 12384979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Cdc25A phosphatase in Hep3B hepatoma cell growth inhibition induced by novel K vitamin analogs.
    Wang Z; Southwick EC; Wang M; Kar S; Rosi KS; Wilcox CS; Lazo JS; Carr BI
    Cancer Res; 2001 Oct; 61(19):7211-6. PubMed ID: 11585757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatoma cell growth in vitro by arylating and non-arylating K vitamin analogs. Significance of protein tyrosine phosphatase inhibition.
    Nishikawa Y; Wang Z; Kerns J; Wilcox CS; Carr BI
    J Biol Chem; 1999 Dec; 274(49):34803-10. PubMed ID: 10574951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic effect through fas/APO-1 expression due to vitamin K in human glioma cells.
    Sun LK; Yoshii Y; Miyagi K
    J Neurooncol; 2000 Mar; 47(1):31-8. PubMed ID: 10930097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins.
    Osada S; Osada K; Carr BI
    J Mol Biol; 2001 Dec; 314(4):765-72. PubMed ID: 11733995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growth inhibitory effects of vitamins K and their actions on gene expression.
    Wang Z; Wang M; Finn F; Carr BI
    Hepatology; 1995 Sep; 22(3):876-82. PubMed ID: 7657295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell growth inhibition by a novel vitamin K is associated with induction of protein tyrosine phosphorylation.
    Ni R; Nishikawa Y; Carr BI
    J Biol Chem; 1998 Apr; 273(16):9906-11. PubMed ID: 9545333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of cytotoxicity of menadione sodium bisulfite versus leukemia L1210 by the acid-soluble thiol pool.
    Akman SA; Dietrich M; Chlebowski R; Limberg P; Block JB
    Cancer Res; 1985 Nov; 45(11 Pt 1):5257-62. PubMed ID: 2996758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of fluoro- and hydroxy-derivatives of vitamin K as substrates or inhibitors of the liver microsomal vitamin K-dependent carboxylase.
    Grossman CP; Suttie JW
    Biofactors; 1992 Jan; 3(3):205-9. PubMed ID: 1599614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action.
    Noto V; Taper HS; Jiang YH; Janssens J; Bonte J; De Loecker W
    Cancer; 1989 Mar; 63(5):901-6. PubMed ID: 2914296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of novel vitamin K analog induced growth inhibition in human hepatoma cell line.
    Osada S; Carr BI
    J Hepatol; 2001 May; 34(5):676-82. PubMed ID: 11434613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of the antiproliferative effect of vitamin K3 on Jurkat cells.
    Kovalenko DV; Zelenin AV
    Biochemistry (Mosc); 1999 Apr; 64(4):468-72. PubMed ID: 10231603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis-inducing activity of vitamin C and vitamin K.
    Sakagami H; Satoh K; Hakeda Y; Kumegawa M
    Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):129-43. PubMed ID: 10726979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth control and gene expression in a new hepatocellular carcinoma cell line, Hep40: inhibitory actions of vitamin K.
    Bouzahzah B; Nishikawa Y; Simon D; Carr BI
    J Cell Physiol; 1995 Dec; 165(3):459-67. PubMed ID: 7593224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of c-Myc in growth inhibition of Hep 3B human hepatoma cells by a vitamin K analog.
    Ge L; Wang Z; Wang M; Kar S; Carr BI
    J Hepatol; 2004 Nov; 41(5):823-9. PubMed ID: 15519656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERK.
    Kar S; Wang M; Ham SW; Carr BI
    Cancer Biol Ther; 2006 Oct; 5(10):1340-7. PubMed ID: 16969075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition and protein tyrosine phosphorylation in MCF 7 breast cancer cells by a novel K vitamin.
    Kar S; Carr BI
    J Cell Physiol; 2000 Dec; 185(3):386-93. PubMed ID: 11056008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of extracellular signal-regulated kinase phosphorylation on menadione (vitamin K3) induced growth inhibition.
    Osada S; Saji S; Osada K
    Cancer; 2001 Mar; 91(6):1156-65. PubMed ID: 11267961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of two growth inhibitory K vitamin analogs on cell cycle regulating proteins in human hepatoma cells.
    Markovits J; Wang Z; Carr BI; Sun TP; Mintz P; Le Bret M; Wu CW; Wu FY
    Life Sci; 2003 May; 72(24):2769-84. PubMed ID: 12679193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.